About this item
Product details
Diampa LXR is a triple-combination oral therapy for the management of type 2 diabetes in adults. This specific formulation combines a higher 12.5mg dose of Empagliflozin (an SGLT2 inhibitor), a standard 2.5mg dose of Linagliptin (a DPP-4 inhibitor), and a full 1000mg dose of Metformin (a biguanide). It is designed for patients requiring intensive glucose-lowering effects with the added benefits of cardiovascular and renal protection from Empagliflozin, along with weight-neutral or weight-loss potential Enhanced Glucose Excretion: The higher 12.5mg Empagliflozin dose increases urinary glucose removal for stronger glycemic control. Heart & Kidney Benefits: Empagliflozin offers proven cardiovascular and renal protective advantages for eligible patients. Composition Each film-coated tablet contains: Empagliflozin: 12.5 mg Linagliptin: 2.5 mg Metformin HCI USP: 1000 mg (as extended release) Directions for Use As directed by the physician.
- Medicines
- 14 Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Getz Pharma
- SKU
- 08964003891602
- Variant
- 14 Tablets
- Tags
- Empagliflozin, Linagliptin, Medicine, Metformin
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
